Interferon-γ and Tumor Necrosis Factor-α: Treatment of ex vivo human carcinoma cells potentiates their interaction with allogeneic lymphocytes

Journal of Interferon and Cytokine Research

Volumn 16, Issue 3, 1996, Pages 201-207

  Vánky, Farkas ^a,b   Hising, Christina ^b   Sjöwall, Kerstin ^b   Larsson, Barbro ^b   Klein, Eva ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER IMMUNOTHERAPY; CELL INTERACTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LUNG CARCINOMA; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; OVARY CARCINOMA; PRIORITY JOURNAL;

ANTIGENS, CD80; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL COMMUNICATION; CYTOTOXICITY, IMMUNOLOGIC; DRUG EVALUATION, PRECLINICAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029932812     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.201     Document Type: Article

References (29)

1. VÁNKY, F., and KLEIN, E. (1991). Requirement of MHC class I antigen expression on human tumors for in vitro recognition by autologous blood lymphocytes. In: MHC Antigen Expression. I. Human Tumors. F. Garrido and E. Klein (eds.) Philadelphia: Saunders, Vol. 2, pp. 55-62.
2. WALLACH, D., FELLOUS, M., and REVEL, M. (1982). Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature 299, 833-836.
3. COLLINS, T., LAPIERRE, L.A., FIERS, W., STROMINGER, J.L., and POBER, J.S. (1986). Recombinant human tumor necrosis factor increase in RNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc. Natl. Acad. Sci. USA 83, 446-452.
4. AVILA-CARINO, J., TORSTEINSDOTTIR, S., BEJARANO, M.T., KLEIN, G., KLEIN, E., and MASUCCI, M.G. (1988). Combined treatment with IFN-γ and TNF-α up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines. Cell. Immunol. 117, 303-311.
5. BISHARA, A., BRAUTBAR, C., NAGLER, A., SLAVIN, S., LESHEM, B., COHEN, I., and KEDAR, E. (1994). Prediction by modified mixed leukocyte reaction assay of graft-versus-host disease and graft rejection after allogeneic bone marrow transplantation. Transplantation 57, 1474-1479.
6. VÁNKY, F., STUBER, G., ROTSTEIN, S., and KLEIN, E. (1989). Autotumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC antigen negative tumor cells. Cancer Immunol. Immunother. 28, 17-21.
7. VÁNKY, F., HISING, C., SJÖWALL, K., LARSSON, B., RODRIGUEZ, L., ORRE, L., and KLEIN, E. (1995). Immunogenicity and immunosensitivity of ex-vivo human carcinomas: Interferon γ and tumor necrosis factor α treatment of tumor cells potentiates their interaction with autologous blood lymphocytes. Cancer Immunol. Immunother. 41, 217-226.
8. VÁNKY, F., KLEIN, E., WILLEMS, J., BÖÖK, K., IVERT, T., and PÉTERITY, A. (1987). Recognition of autologous tumor cells by blood lymphocytes in patients with lung cancer. In: Immunology of Malignant Disease. V.S. Byers and R.W. Baldwin (eds.) London: MTP Press, pp. 105-127.
9. BØYUM, A. (1974). Separation of blood leukocytes, granulocytes and lymphocytes. Tissue Antigens 4, 269-274.
10. JULIUS, M.H., SIMPSON, E., and HERZENBERG, L.A. (1973). Rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3, 645-649.
11. CLARK, E.A., LEDBETTER, E.A., HOLLY, R.C., DINNDORF, P.A., and SHU, G. (1986). Polypeptides on human B lymphocytes associated with cell activation. Hum. Immunol. 16, 100-107.
12. VÁNKY, F., WILLEMS, J., KREICBERGS, A., APARISI, T., ANDRÉEN, M., BROSTRÖM, L.-Å., NILSONNE, U., KLEIN, E., and KLEIN, G. (1983). Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course. Cancer Immunol. Immunother. 16, 11-16.
13. MASUCCI, M.G., KLEIN, E., and ARGOV, S. (1980). Disappearance of the NK effect after explantation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated cultures. J. Immunol. 124, 2458-2463.
14. VÁNKY, F., STUBER, G., WILLEMS, J., SJÖWALL, K., LARSSON, B., BÖÖK, K., IVERT, T., PÉTERFFY, A., and KLEIN, E. (1988). Importance of MHC antigen expression on solid tumors in the in vitro interaction with autologous blood lymphocytes. Cancer Immunol. Immunother. 27, 213-222.
15. CARLOW, D., KERBEL, R., and ELLIOTT, B. (1989). Failure of expression of class I major histocompatibility antigens to alter tumor immunogenicity of a spontaneous murine carcinoma. J. Natl. Cancer Inst. 81, 759-767.
16. VÁNKY, F., ARGOV, S., and KLEIN, E. (1981). Tumor biopsy cells participating in system in which cytotoxicity of lymphocytes is generated. Autologous and allogeneic studies. Int. J. Cancer 27, 273-280.
17. GROSSMAN, Z. (1993). Cellular tolerance as a dynamic state of the adaptable lymphocytes. Immunol. Rev. 133, 45-73.
18. BONGRAND, P., PIERRES, M., and GOLSTEIN, P. (1983). T cell-mediated cytolysis: on the strength of effector-target interaction. Eur. J. Immunol. 13, 424-429.
19. MARYANSKI, J.L., PALA, P., CEROTTINI, J.-C., and MACDONALD, R.H. (1988). Antigen recognition by H-2-restricted cytotoxic T lymphocytes: inhibition of cytolysis by anti-CD8 monoclonal antibodies depends upon both concentration and primary sequence of peptide antigen. Eur. J. Immunol. 18, 1863-1866.
20. COLE, G., CLEMENTS, V., GARCIA, E., and OSTRAND-ROSENBERG, S. (1987). Allogeneic H-2 antigen expression is insufficient for tumor rejection. Proc. Natl. Acad. Sci. USA 84, 8613-8617.
21. HERSEY, P., SI, Z., SMITH, M., and THOMAS, W. (1994). Expression of the costimulatory molecule B7 on melanoma cells. Int. J. Cancer 58, 527-532.
22. + cytotoxic T lymphocytes. Eur. J. Immunol. 23, 418-424.
23. KLEIN, G., KLEIN, E., and HAUGHTON, G. (1966). Variation of antigenic characteristics between different mouse lymphomas induced by the moloney virus. J. Natl. Cancer Inst. 36, 607-621.
24. KOEPPEN, H., ACENA, M., DROLET, A., ROWLEY, D.A., and SCHREIBER, H. (1993). Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytes. Eur. J. Immunol. 23, 2770-2776.
25. + T cells to an antigen that no longer serves as target. J. Exp. Med. 178, 933-940.
26. SRIVASTAVA, P.K. (1993). Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation. Adv. Cancer Res. 62, 153-177.
27. FRUH, K., GOSSEN, M., WANG, K., BUJARD, H., PETERSON, P., and YANG, Y. (1994). Displacement of housekeeping proteosome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J. 13, 3236-3244.
28. BOES, B., HENGEL, H., RUPPERT, T., MULTHAUP, G., KOSZINOWSKI, U., and KLOETZEL, P. (1994). IFN-gamma stimulation modulates the protelytic activity and cleavage site preference of 20S mouse proteosomes. J. Exp. Med. 179, 901-909.
29. BROWN, M., DRISCOLL, J., and MONACO, J. (1993). MHC-linked low-molecular mass polypeptide subunits define distinct subsets of proteosomes. Implications for divergent function among distinct proteosome subsets. J. Immunol. 151, 1193-1204.